Shopping Cart
- Remove All
- Your shopping cart is currently empty
C086 is a novel and potent Hsp90 inhibitor that suppresses cell cycle progression, induces apoptosis, and exhibits anti-metastatic properties by modulating various mechanisms in different cell types.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | C086 is a novel and potent Hsp90 inhibitor that suppresses cell cycle progression, induces apoptosis, and exhibits anti-metastatic properties by modulating various mechanisms in different cell types. |
In vitro | When used in conjunction with gefitinib, C086 impairs the molecular chaperone function of Hsp90 in non-small cell lung cancer (NSCLC) cells. |
Molecular Weight | 504.53 |
Formula | C29H28O8 |
Cas No. | 1160107-44-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.